Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 Fresenius Medical Care AG & Co. KGaA: Release of a capital market information 23.04.2019 / 15:28 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. - Share buy-back - 6th Interim Report In the period from 15 April 2019 until and including 18 April 2019, a total of 809,692 shares were repurchased within the framework of the share buyback programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on 11 March 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF): XETRA Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 15/04/2019 136,245 73.8151 16/04/2019 70,565 74.1171 17/04/2019 202,800 72.3830 18/04/2019 188,339 70.2890 Chi-X Europe Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 17/04/2019 44,000 71.8306 18/04/2019 40,948 70.2777 BATS Europe Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 17/04/2019 53,000 71.8378 18/04/2019 50,595 70.2695 Turquoise Day of repurchase Aggregated volume in Weighted average share number of shares price in EUR 17/04/2019 13,200 71.6319 18/04/2019 10,000 70.1659 The total volume of shares repurchased within the framework of this share buy-back in the period from 12 March 2019 until and including 18 April 2019 therefore amounts to 3,369,737 shares. Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors. Fresenius Medical Care AG & Co. KGaA represented by Fresenius Medical Care Management AG represented by its Management Board Bad Homburg v.d.H., 23 April 2019 23.04.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News	DGAP News Service

802385  23.04.2019